539 related articles for article (PubMed ID: 32038653)
1. Manipulation of the Innate Immune Response by Varicella Zoster Virus.
Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A
Front Immunol; 2020; 11():1. PubMed ID: 32038653
[TBL] [Abstract][Full Text] [Related]
2. Varicella zoster virus immune evasion strategies.
Abendroth A; Kinchington PR; Slobedman B
Curr Top Microbiol Immunol; 2010; 342():155-71. PubMed ID: 20563710
[TBL] [Abstract][Full Text] [Related]
3. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
[TBL] [Abstract][Full Text] [Related]
4. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
5. Review: The neurobiology of varicella zoster virus infection.
Gilden D; Mahalingam R; Nagel MA; Pugazhenthi S; Cohrs RJ
Neuropathol Appl Neurobiol; 2011 Aug; 37(5):441-63. PubMed ID: 21342215
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies.
Hakami MA; Khan FR; Abdulaziz O; Alshaghdali K; Hazazi A; Aleissi AF; Abalkhail A; Alotaibi BS; Alhazmi AYM; Kukreti N; Binshaya AS
Rev Med Virol; 2024 Jul; 34(4):e2554. PubMed ID: 38862398
[TBL] [Abstract][Full Text] [Related]
7. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on vaccines against varicella-zoster virus infections.
Gershon AA; Gershon MD
Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
[TBL] [Abstract][Full Text] [Related]
9. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
Amlie-Lefond C; Gilden D
J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
[TBL] [Abstract][Full Text] [Related]
10. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
[TBL] [Abstract][Full Text] [Related]
11. Immunological evasion of immediate-early varicella zoster virus proteins.
Meysman P; Fedorov D; Van Tendeloo V; Ogunjimi B; Laukens K
Immunogenetics; 2016 Jul; 68(6-7):483-486. PubMed ID: 27020058
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of Cytokine Signaling 3 Expression Induced by Varicella-Zoster Virus Infection Results in the Modulation of Virus Replication.
Choi EJ; Lee CH; Shin OS
Scand J Immunol; 2015 Oct; 82(4):337-44. PubMed ID: 26072679
[TBL] [Abstract][Full Text] [Related]
13. Molecular and therapeutic aspects of varicella-zoster virus infection.
Quinlivan M; Breuer J
Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
[TBL] [Abstract][Full Text] [Related]
14. The effect of vaccination on the epidemiology of varicella zoster virus.
Edmunds WJ; Brisson M
J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
[TBL] [Abstract][Full Text] [Related]
15. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
Wittek AE; Arvin AM; Koropchak CM
J Clin Microbiol; 1983 Nov; 18(5):1146-9. PubMed ID: 6315766
[TBL] [Abstract][Full Text] [Related]
16. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
[TBL] [Abstract][Full Text] [Related]
17. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
Harper DR; Grose C
J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for varicella-zoster virus infections.
Andrei G; Snoeck R
Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
[TBL] [Abstract][Full Text] [Related]
19. VZV infection of keratinocytes: production of cell-free infectious virions in vivo.
Gershon MD; Gershon AA
Curr Top Microbiol Immunol; 2010; 342():173-88. PubMed ID: 20225011
[TBL] [Abstract][Full Text] [Related]
20. RNA Polymerase III as a Gatekeeper to Prevent Severe VZV Infections.
Carter-Timofte ME; Paludan SR; Mogensen TH
Trends Mol Med; 2018 Oct; 24(10):904-915. PubMed ID: 30115567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
